Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study

Although dopaminergic agents are the drugs of choice in treatment of prolactin excess, women who cannot be treated with these agents are recommended to receive estrogen preparations. The aim of this study was to compare cardiometabolic effects of both treatment options. The study population included...

Descripción completa

Detalles Bibliográficos
Autores principales: Krysiak, Robert, Kowalcze, Karolina, Okopień, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179073/
https://www.ncbi.nlm.nih.gov/pubmed/37176648
http://dx.doi.org/10.3390/jcm12093208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179073/
https://www.ncbi.nlm.nih.gov/pubmed/37176648
http://dx.doi.org/10.3390/jcm12093208

Ejemplares similares